When we launched Breakthroughs Today, Cures Tomorrow, we made a promise: accelerate the science that leads to better treatments and, ultimately, cures. The momentum is real. And the numbers prove it.
When we opened our latest Request for Applications — our call to researchers worldwide to bring forward their boldest ideas — we didn’t just get a strong response. We got a signal.
Our letters of intent submissions increased by over 35%. That’s not just growth. That’s the field speaking. New ideas are emerging. Researchers are engaging. And the urgency to make progress — right now — has never been more palpable.
Your support is why that’s happening.
How This Funding Is Meeting the Moment
NETRF funds work others won’t — early-stage ideas, bold approaches, and high-potential science that hasn’t yet earned a place in traditional funding pipelines. We also help move the most promising discoveries forward, bridging the gap between laboratory breakthroughs and the patients who need them.
The proposals we’re seeing this cycle reflect the breadth of what’s needed to better understand this disease and bring new treatments closer to patients:
- Foundational science to better understand how neuroendocrine tumors develop and behave
- Translational research developing new, more effective treatments
- Pilot projects and large collaborative efforts spanning institutions and countries
Together, this work advances our Research Roadmap: earlier detection, better treatment options, and more personalized care for every patient.
Step by step, your support turns into real progress for real people.
The energy we’re seeing right now — the ideas pouring in, the collaborations forming, the sheer determination in this field — exists because of this community. Because of you.
We are not waiting for progress. We are building it together. Thank you for being part of this work, and for helping bring better treatments — and hope — closer to every person affected by neuroendocrine cancer.
Every dollar you give fuels the next breakthrough. Join us in advancing research for neuroendocrine cancer. Support NETRF research.